Abstract: An embodiment multi-way coolant valve includes an outer housing including a first outer inlet, a second outer inlet, a third outer inlet, a fourth outer inlet, a first outer outlet, and a second outer outlet, an inner housing rotatably provided within the outer housing and configured to define a coolant flow path, and a driving unit connected to a first rotation center of the inner housing and configured to selectively rotate the inner housing within the outer housing, wherein, as the inner housing rotates by a preset interval according to a selected mode of a vehicle, the first outer inlet or the second outer inlet selectively communicates with the first outer outlet, and the third outer inlet or the fourth outer inlet selectively communicates with the second outer outlet.

Abstract: An embodiment multi-way coolant valve includes an outer housing including first to third outer inlets, first to third outer outlets, and a pump mount portion coupled to one of the outer outlets, an inner housing rotatably provided within the outer housing and including penetration holes corresponding to the outer inlets and outlets, a coolant line defined by a selective connection of the penetration holes such that the outer inlets and outlets are selectively connected, pads interposed between an interior circumference of the outer housing and an exterior circumference of the inner housing at locations of the outer inlets and outlets, respectively, and a driving device connected to a rotation center of the inner housing to selectively rotate the inner housing within the outer housing, wherein the inner housing is configured to rotate by a preset interval according to a selected vehicle mode.

Abstract: A server is disclosed. The server comprises: a communication interface for communicating with a user terminal device and an electronic device; a storage for storing healthcare information corresponding to an avatar of a user; and a processor for acquiring the healthcare information corresponding to the avatar of the user from the storage when information including the avatar of the user and health data is received from the user terminal device, and controlling the communication interface such that guide information for guiding user behavior is transmitted to the user terminal device and/or the electronic device on the basis of the acquired healthcare information and the received health data.

Abstract: A reflectionless window is disclosed. The reflectionless window comprises: a transparent window; a plurality of first nanocolumns arranged on a first surface of the transparent window; and a plurality of second nanocolumns having a height smaller than that of the first nanocolumns, the plurality of second nanocolumns being arranged on at least one surface selected from the upper surface of the plurality of first nanocolumns and a side surface thereof and being arranged in an area on the first surface of the transparent window in which the plurality of first nanocolumns are not arranged.

Abstract: A wearable body composition analyzer according to various embodiments of the present disclosure may include an induction part for inducing secretion of bodily liquid while being in contact with a body part, a collection part that collects the bodily liquid secreted, a sensor part that detects a body composition from the bodily liquid collected, and a wearable part to which the induction part and the collection part is detachably attached, wherein the wearable part may be worn on a body. The above-described wearable body composition analyzer may be implemented variously according to embodiments.

Abstract: Disclosed is a glucose measuring apparatus including a pressure measurer having an elastic part or a pressure sensor, that measures a pressure applied to an object, a film that comprises a first optical waveguide configured to be close to the object, a near infrared ray (NIR) irradiator that irradiates an NIR to the first optical waveguide if the measured pressure is greater than or equal to a preset value, an NIR receiver that receives an attenuated total reflection NIR (ATR-NIR) from the first optical waveguide, and an analyzer that measures a blood glucose level based on the ATR-NIR, wherein the film is an independent module that can be combined with and separated from the glucose measuring apparatus.

Abstract: Disclosed is an apparatus for measuring bio signals. The apparatus for measuring bio signals includes: a sensor module configured to include a needle sensor to be inserted into the skin; and a main body to which the sensor module is separably coupled, and which is configured to include a controller controlling the sensor module to measure a bio signal through the needle sensor, once the sensor module is coupled.

Abstract: Disclosed is a manufacturing method for a bio-sensor. The present manufacturing method comprise the steps of: preparing an acidic solution comprising an enzyme and a molecule containing a catechol group; an immersing electrodes in the acidic solution and applying a voltage to the electrodes, thereby attaching a structure, which is generated by a reaction of the enzyme and the molecule containing a catechol group, to the electrodes.

Abstract: Provided are an electronic device and a method for controlling the same. An electronic device for providing continuous blood glucose monitoring comprises: a first sensor for measuring a glucose level of an interstitial fluid in order to predict blood glucose; a second sensor disposed on an inner surface of the electronic device to be in contact with a human body, in order to measure at least one of a blood flow and a heart rate of the human body; and a processor for determining a diffusion time during which glucose present in blood diffuses into the interstitial fluid, on the basis of characteristics of a signal generated by the second sensor, and predicting the blood glucose on the basis of the glucose level measured by the first sensor and the determined diffusion time.

Abstract: Methods and apparatuses for blood glucose measurement are provided. A first glucose concentration in a body fluid of a user is detected based on a first measurement interval. A first blood glucose level of the user is determined based on the first glucose concentration. A glucose concentration measurement interval is changed from the first measurement interval to a second measurement interval according to an occurrence of an event. A second glucose concentration in the body fluid is detected based on the second measurement interval. A second blood glucose level of the user is determined based on the second glucose concentration.

Abstract: A biometric information measuring sensor is provided that includes a base comprising a plurality of bio-marker measuring areas and a plurality of electrodes. Each of the plurality of electrodes is disposed on a respective one of the plurality of bio-marker measuring areas, and each of the plurality of electrodes includes a working electrode and a counter electrode spaced apart from the working electrode. The biometric information measuring sensor also includes a plurality of needles. Each of the needles is disposed on a respective one of the plurality of electrodes. Two or more of the plurality of needles have different lengths.

Abstract: Provided is a wireless electrocardiogram monitoring device comprising: a patch part including a plurality of electrodes; and a module part detachably coupled to the patch part and capable of wireless communication with an external device, wherein the patch part comprises: a downward patch part formed at the bottom surface to be attached to the human body while some of the plurality of electrodes are exposed from the bottom surface; and an upward patch part disposed at the top surface opposite to the bottom surface while the others of the plurality of electrodes are exposed from the top surface.

Abstract: Disclosed is a biosensor. The biosensor comprises: an electrode; and a polymer structure disposed on the electrode and formed of poly-5,2?:5?,2?-terthiophene-3-carboxylic acid (pTTCA), wherein an enzyme is present in a state of covalently binding with pTTCA inside the polymer structure.

Abstract: A blood glucose measurement device is disclosed. The present blood glucose measurement device comprises: a substrate; a first resonance sensor and a second resonance sensor arranged on the substrate; and a shield layer arranged below the second resonance sensor with respect to the direction from the second resonance sensor toward a subject.

Abstract: Disclosed is a wearable electronic device including a body portion wearable on a human body, a circuit portion mounted on the body portion, and a sensor portion contacting the human body to measure a bio signal, wherein the sensor portion is detachably coupled to the body portion.

Abstract: A blood glucose measurement apparatus includes: a control unit configured to determine a user's blood glucose level based on a concentration of body fluid secreted from the user; and a biometric information acquisition unit configured to acquire biometric information indicating a status of a user's autonomic nervous system. The control unit is configured to correct the determined blood glucose level based on the biometric information.

Abstract: Disclosed are a blood glucose measuring device, a blood glucose measuring system, and a method for measuring blood glucose using the blood glucose measuring device. The present blood glucose measuring device comprises: a sensor for measuring blood glucose via a body fluid of a user; and a processor for obtaining error information of the sensor by comparing a first blood glucose level measured by the sensor, and a second blood glucose level measured via the blood of the user, at a first calibration interval during a preset time; calculating the time taken for the error range of the sensor to reach a preset threshold value, on the basis of the first calibration interval and the error information of the sensor; and setting the first calibration interval as a second calibration interval on the basis of the calculated time.

Abstract: An electronic device and a control method therefor are disclosed. The electronic device control method according to the present invention comprises the steps of: receiving blood glucose information and skin temperature information from a blood glucose meter; obtaining external temperature information of a region in which a user wearing the blood glucose meter is located; determining, by using the skin temperature information and the external temperature information, the predictive temperature of an inner skin part at which an enzyme sensor of the blood glucose meter is located; correcting the blood glucose information on the basis of the determined predictive temperature; and outputting the corrected blood glucose information.

Abstract: Disclosed is an apparatus for measuring bio signals. The apparatus for measuring bio signals includes: a sensor module configured to include a needle sensor to be inserted into the skin; and a main body to which the sensor module is separably coupled, and which is configured to include a controller controlling the sensor module to measure a bio signal through the needle sensor, once the sensor module is coupled.

Abstract: Disclosed is a glucose measuring apparatus including a pressure measurer having an elastic part or a pressure sensor, that measures a pressure applied to an object, a film that comprises a first optical waveguide configured to be close to the object, a near infrared ray (NIR) irradiator that irradiates an NIR to the first optical waveguide if the measured pressure is greater than or equal to a preset value, an NIR receiver that receives an attenuated total reflection NIR (ATR-NIR) from the first optical waveguide, and an analyzer that measures a blood glucose level based on the ATR-NIR, wherein the film is an independent module that can be combined with and separated from the glucose measuring apparatus.